RET Fusion mutation drugs – lung cancer

Activated RET and ROS: two new driver mutations in lung adenocarcinoma

Anti-aging combo on Amazon

Amazon links. N (R) Niagen Nicotinamide Riboside Pterostilbene Longevity and Antioxidant Supplement Pterostilbene inhibits lung cancer through induction of apoptosis.   NAD+ and SIRT1: Their Role In Chronic Health Issues

Cancer Notes

Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells Inhibitors of RET, a tyrosine kinase receptor encoded by a gene that is frequently mutated in medullary thyroid cancer, have emerged as promising novel therapies for the disease. Rapalogs and other mammalian target of rapamycin (mTOR) inhibitors are effective agents in patients with […]